Scientists believe they can identify which HIV strains cause infection

July 21, 2014 by Laura Bailey

(Medical Xpress)—HIV-infected people carry many different HIV viruses and all have distinct personalities—some much more vengeful and infectious than others.

Yet, despite the breadth of infectivity, roughly 76 percent of HIV infections arise from a single virus. Now, scientists believe they can identify the culprit with very specific measurements of the quantities of a in the HIV virus.

Quantifying this key protein may reveal which of the many present actually caused the infection.

The University of Michigan study is thought to be the first in which researchers were able to capture HIV at the single-particle level and measure with molecular resolutions, said principal investigator Wei Cheng of the U-M College of Pharmacy. Cheng's group found that the HIV virus particles have different quantities of a key protein that enables virulence, and the protein-rich were more infectious than the others.

"There were significant molecular differences in the HIV viral particles—some were very dangerous and infectious, and some were more tame. The virus was very heterogeneous," Cheng said. "Our technique lets us see differences down to the single molecule level, so if one virus particle differs from another by even one molecule, our instrument can detect that."

Now that scientists can measure molecular differences in HIV viral particles, there's a possibility that drugs could be developed to target the molecular features present in the more virulent strains, he said.

Cheng's lab developed and used a new optical technique, which is outlined in a previous paper, to measure the particles.

To study the HIV viral particles, the U-M team improved upon an already existing tool called optical tweezers, which uses photons, or light, to manipulate tiny molecular motors or nanostructures. This immobilizes the structure and enables contact-free study that doesn't disturb or distort the structure.

This new U-M optical technique gives rise to a couple different research directions for Cheng's lab, he said. Scientists can now infect individual cells with single HIV viral particles to determine the particle's virulence. This technique also has the potential for sorting of viruses and application in other deadly viruses. Ultimately, Cheng said they hope to learn which strains of HIV contain the most dangerous most likely to infect healthy cells.

The study, "Optical trapping of individual human immunodeficiency viruses in culture fluid reveals heterogeneity with single-molecule resolution," is scheduled for online publication July 20 in Nature Nanotechnology.

Explore further: HIV can cut and paste in the human genome

More information: "Optical trapping of individual human immunodeficiency viruses in culture fluid reveals heterogeneity with single-molecule resolution." Yuanjie Pang, et al. Nature Nanotechnology (2014) DOI: 10.1038/nnano.2014.140. Received 13 February 2014 Accepted 12 June 2014 Published online 20 July 2014

Related Stories

HIV can cut and paste in the human genome

May 27, 2014
For the first time researchers have succeeded in altering HIV virus particles so that they can simultaneously, as it were, 'cut and paste' in our genome via biological processes. Developed at the Department of Biomedicine ...

Seeing through HIV's disguises: Researchers identify 25 human proteins that may be crucial for HIV-1 infection

February 27, 2013
Studying HIV-1, the most common and infectious HIV subtype, Johns Hopkins scientists have identified 25 human proteins "stolen" by the virus that may be critical to its ability to infect new cells. HIV-1 viruses capture many ...

Scientists find the invisibility cloak that shields HIV-1 from the immune system

November 21, 2013
Of the two major types of HIV, only one, HIV-1, typically causes AIDS in infected people who don't receive treatment. A study published by Cell Press November 21st in the journal Immunity reveals how HIV-1 escapes detection ...

Kinesin 'chauffeur' helps HIV escape destruction

October 22, 2012
A study in The Journal of Cell Biology identifies a motor protein that ferries HIV to the plasma membrane, helping the virus escape from macrophages.

Why and how anti-retroviral therapy works even against HIV cell-to-cell transmission

February 27, 2014
The discovery of direct cell-to-cell transmission of HIV, and the finding that some anti-HIV drugs don't seem active against virus that spreads that way, have caused questions and concern. A study published on February 27th ...

Recommended for you

Paris spotlight on latest in AIDS science

July 21, 2017
Some 6,000 HIV experts gather in Paris from Sunday to report advances in AIDS science as fading hopes of finding a cure push research into new fields.

Scientists elicit broadly neutralizing antibodies to HIV in calves

July 20, 2017
Scientists supported by the National Institutes of Health have achieved a significant step forward, eliciting broadly neutralizing antibodies (bNAbs) to HIV by immunizing calves. The findings offer insights for HIV vaccine ...

Heart toxin reveals new insights into HIV-1 integration in T cell genome

July 20, 2017
Human immunodeficiency virus (HIV)-1 may have evolved to integrate its genetic material into certain immune-cell-activating genes in humans, according to new research published in PLOS Pathogens.

Scientists capture first high-resolution image of key HIV protein transitional state

July 13, 2017
A new, three-dimensional snapshot of HIV demonstrates the radical structural transformations that enable the virus to recognize and infect host cells, according to a new study led by scientists at The Scripps Research Institute ...

Barrier to autoimmune disease may open door to HIV, study suggests

July 11, 2017
Researchers from the University of Colorado School of Medicine have discovered that a process that protects the body from autoimmune disease also prevents the immune system from generating antibodies that can neutralize the ...

Team tests best delivery mode for potential HIV vaccine

June 20, 2017
For decades, HIV has successfully evaded all efforts to create an effective vaccine but researchers at The Scripps Research Institute (TSRI) and the La Jolla Institute for Allergy and Immunology (LJI) are steadily inching ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.